Do you or perhaps jq know how Replagal and Fabrazyme both got on the market in the EU but Genzyme beat TKT in the US and through Orphan drug there kept them off the market? (Thats when I became a shareholder in TKT)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.